Browse

Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells

DC Field Value Language
dc.contributor.authorOh, Jung-Min-
dc.contributor.authorKim, Su-Hyeong-
dc.contributor.authorLee, Yun-Il-
dc.contributor.authorSeo, Miran-
dc.contributor.authorSong, Yong-Sang-
dc.contributor.authorJuhnn, Yong-Sung-
dc.contributor.authorKim, Woo-Ho-
dc.contributor.authorKim, So-Young-
dc.date.accessioned2012-06-26T00:13:45Z-
dc.date.available2012-06-26T00:13:45Z-
dc.date.issued2009-01-
dc.identifier.citationCARCINOGENESIS; Vol.30 1; 141-149ko_KR
dc.identifier.issn0143-3334-
dc.identifier.urihttp://hdl.handle.net/10371/77407-
dc.description.abstractHuman papillomavirus (HPV) is the major cause of uterine cervical cancer, but the role of the HPV E5 in carcinogenesis is not clearly understood. Prostaglandins are known to contribute to carcinogenesis of cervical cancer, and we therefore investigated the effect of HPV16 E5 on the expression of prostaglandin E2 (PGE2) receptors and underlying mechanisms. Stable expression of the E5 induced expression of the EP4 subtype of PGE2 receptors in C33A cervical cancer cells, and transfection of E5 small interfering RNA (siRNA) decreased it. EP4 protein expression was increased in human cervical cancer tissues, and EP4 mediated E5-induced increase in anchorage-independent colony formation and vascular endothelial growth factor expression. E5 induced cyclooxygenase-2 (COX-2) expression, and COX-2 increased PGE2 secretion and EP4 expression. The induction of EP4 by PGE2 and E5 was inhibited by an EP4 antagonist, inhibitors of cyclic adenosine monophosphate-dependent protein kinase or phosphatidylinositol 3-kinase, and a cyclic adenosine monophosphate response element (CRE) decoy. E5 increased the luciferase expression controlled by a variant CRE of the EP4 promoter, and it also increased the binding of cyclic adenosine monophosphate response element binding protein (CREB) to oligonucleotides containing this CRE. We conclude that the HPV16 E5 protein induces EP4 receptor protein in cervical cancer cells and that this induction involves epidermal growth factor receptor, COX-2, PGE2, EP2 and EP4, protein kinase A, CREB and CRE.ko_KR
dc.language.isoenko_KR
dc.publisherOXFORD UNIV PRESSko_KR
dc.titleHuman papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cellsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor오정민-
dc.contributor.AlternativeAuthor김수형-
dc.contributor.AlternativeAuthor이윤일-
dc.contributor.AlternativeAuthor서미란-
dc.contributor.AlternativeAuthor김소영-
dc.contributor.AlternativeAuthor송용상-
dc.contributor.AlternativeAuthor김우호-
dc.contributor.AlternativeAuthor전용성-
dc.identifier.doi10.1093/carcin/bgn236-
dc.citation.journaltitleCARCINOGENESIS-
dc.description.citedreferenceKim SY, 2008, J BIOL CHEM, V283, P1350, DOI 10.1074/jbc.M702344200-
dc.description.citedreferenceLee HS, 2007, INT J ONCOL, V31, P859-
dc.description.citedreferenceCherukuri DP, 2007, EXP CELL RES, V313, P2969, DOI 10.1016/j.yexcr.2007.06.004-
dc.description.citedreferenceChun KS, 2007, MOL CARCINOGEN, V46, P699, DOI 10.1002/mc.20354-
dc.description.citedreferenceMaufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921-
dc.description.citedreferenceSiu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x-
dc.description.citedreferenceHawcroft G, 2007, ONCOGENE, V26, P3006, DOI 10.1038/sj.onc.1210113-
dc.description.citedreferenceSubbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273-
dc.description.citedreferenceHan SW, 2007, J BIOL CHEM, V282, P7961, DOI 10.1074/jbc.M610308200-
dc.description.citedreferenceWoodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050-
dc.description.citedreferenceFulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067-
dc.description.citedreferenceMa XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348-
dc.description.citedreferenceHan SW, 2005, J BIOL CHEM, V280, P33240, DOI 10.1074/jbc.M507617200-
dc.description.citedreferenceZhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102-
dc.description.citedreferenceGENTHERWILLIAMS SM, 2005, CANCER RES, V65, P6534-
dc.description.citedreferenceSpinella F, 2004, J BIOL CHEM, V279, P46700, DOI 10.1074/jbc.M408584200-
dc.description.citedreferenceMuller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y-
dc.description.citedreferenceTherland KL, 2004, J AM SOC NEPHROL, V15, P1189, DOI 10.1097/01.ASN.0000124673.79934.24-
dc.description.citedreferenceBradbury DA, 2003, J BIOL CHEM, V278, P49954, DOI 10.1074/jbc.M307964200-
dc.description.citedreferenceConkright MD, 2003, MOL CELL, V11, P1101-
dc.description.citedreferenceAraki Y, 2003, CANCER RES, V63, P728-
dc.description.citedreferenceFujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200-
dc.description.citedreferenceSales KJ, 2002, CANCER RES, V62, P424-
dc.description.citedreferenceMutoh M, 2002, CANCER RES, V62, P28-
dc.description.citedreferenceFaour WH, 2001, J BIOL CHEM, V276, P31720-
dc.description.citedreferenceSales KJ, 2001, J CLIN ENDOCR METAB, V86, P2243-
dc.description.citedreferenceChang JL, 2001, J BIOMED SCI, V8, P206, DOI 10.1159/000054034-
dc.description.citedreferenceVenuti A, 1998, VIROLOGY, V248, P1-
dc.description.citedreferenceCavuslu S, 1996, CLIN DIAGN VIROL, V5, P215-
dc.description.citedreferenceCOLEMAN RA, 1994, PHARMACOL REV, V46, P205-
dc.description.citedreferenceZUR HH, 1994, ANNU REV MICROBIOL, V48, P427-
dc.description.citedreferenceAN SZ, 1993, BIOCHEM BIOPH RES CO, V197, P263-
dc.description.citedreferenceSTRAIGHT SW, 1993, J VIROL, V67, P4521-
dc.description.citedreferenceJONES DA, 1993, J BIOL CHEM, V268, P9049-
dc.description.citedreferencePIOMELLI D, 1993, J LIPID MEDIATOR, V6, P433-
dc.description.citedreferenceSHERMAN L, 1992, INT J CANCER, V50, P356-
dc.description.citedreferenceLEECHANACHAI P, 1992, ONCOGENE, V7, P19-
dc.description.citedreferenceTISCHER E, 1991, J BIOL CHEM, V266, P11947-
dc.description.citedreferenceFINK JS, 1988, P NATL ACAD SCI USA, V85, P6662-
dc.description.citedreferenceBAKER CC, 1987, J VIROL, V61, P962-
dc.description.citedreferenceSCHWARZ E, 1985, NATURE, V314, P111-
dc.description.tc8-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Pathology (병리학전공)Journal Papers (저널논문_병리학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse